Device Review Templates Are Milestones On Road To “Critical Path” – CBER
This article was originally published in The Gray Sheet
Executive Summary
The Center for Biologics Evaluation & Research is flagging areas of the device review process that can be clarified through "templates" to guide staff and sponsors
You may also be interested in...
Wound-Healing Combo Product Jurisdiction Should Be Clarified – Ex-FDAer
The regulatory pathway for wound-healing combination products should be elucidated because they increasingly are assigned to CBER and not the device center, according to The Biologics Consulting Group Senior Consultant Darin Weber, PhD
Wound-Healing Combo Product Jurisdiction Should Be Clarified – Ex-FDAer
The regulatory pathway for wound-healing combination products should be elucidated because they increasingly are assigned to CBER and not the device center, according to The Biologics Consulting Group Senior Consultant Darin Weber, PhD
CBER Topsider Initiatives Include Role In Device Meetings, Review Templates
The Center for Biologics Evaluation & Research is pledging regular top-level participation in medical device meetings as part of a series of management initiatives for 2004